Expression of nerve growth factor and hypoxia inducible factor-1α and its correlation with angiogenesis in non-small cell lung cancer

Qing-li Lu, Jian Liu, Xiao-li Zhu, Wen-jia Xu

Current Medical Science ›› 2014, Vol. 34 ›› Issue (3) : 359-362.

Current Medical Science ›› 2014, Vol. 34 ›› Issue (3) : 359-362. DOI: 10.1007/s11596-014-1283-3
Article

Expression of nerve growth factor and hypoxia inducible factor-1α and its correlation with angiogenesis in non-small cell lung cancer

Author information +
History +

Abstract

In order to investigate the expression of nerve growth factor (NGF) and hypoxia inducible factor-1α (HIF-1α) and its correlation with angiogenesis in non-small cell lung cancer (NSCLC), paraffin-embedded tissue blocks from 20 patients with NSCLC were examined. Twenty corresponding para-cancerous lung tissue specimens were obtained to serve as a control. The expression of NGF, HIF-1α, and vascular endothelial growth factor (VEGF) in the NSCLC tissues was detected by using immunohistochemistry. The microvascular density (MVD) was determined by CD31 staining. The results showed that the expression levels of NGF, HIF-1α and VEGF in the NSCLC tissues were remarkably higher than those in the para-cancerous lung tissues (P<0.05). There was significant difference in the MVD between the NSCLC tissues (9.19±1.43) and para-cancerous lung tissues (2.23±1.19) (P<0.05). There were positive correlations between NGF and VEGF, between HIF-1α and VEGF, and between NGF and HIF-1α in NSCLC tissues, with the spearman correlation coefficient being 0.588, 0.519 and 0.588, respectively. In NSCLC tissues, the MVD had a positive correlation with the three factors (P<0.05). Theses results suggest that NGF and HIF-1α are synergically involved in the angiogenesis of NSCLC.

Keywords

non-small cell lung cancer / immunohistochemistry / nerve growth factor / hypoxia inducible factor-1α / vascular endothelial growth factor / CD31 / microvascular density

Cite this article

Download citation ▾
Qing-li Lu, Jian Liu, Xiao-li Zhu, Wen-jia Xu. Expression of nerve growth factor and hypoxia inducible factor-1α and its correlation with angiogenesis in non-small cell lung cancer. Current Medical Science, 2014, 34(3): 359‒362 https://doi.org/10.1007/s11596-014-1283-3

References

[1]
FerlayJ, ShinHR, BrayF, et al.. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12): 2893-2917
CrossRef Google scholar
[2]
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer [EB/OL]. (2012-03-05) http://www.nccn.org/professionals/physiciangls/fguide-lines.asp
[3]
SmeyneRJ, KleinR, SchnappA, et al.. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature, 1994, 368(6468): 246-249
CrossRef Google scholar
[4]
MoserKV, ReindlM, BlasigI, et al.. Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation. Brain Res, 2004, 1017(1–2): 53-60
CrossRef Google scholar
[5]
CalzaL, GiardinoL, GiulianiA, et al.. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci USA, 2001, 98(7): 4160-4165
CrossRef Google scholar
[6]
EmanueliC, SalisMB, PinnaA, et al.. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation, 2002, 106(17): 2257-2262
CrossRef Google scholar
[7]
CantarellaG, LempereurL, PrestaM, et al.. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J, 2002, 16(10): 1307-1309
[8]
EggertA, GrotzerMA, IkegakiN, et al.. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma. Med Pediatr Oncol, 2000, 35(6): 569-572
CrossRef Google scholar
[9]
RicciA, GrecoS, MariottaS, et al.. Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol, 2001, 25(4): 439-446
CrossRef Google scholar
[10]
JeanM. How cells endure low oxygen. Science, 2004, 303(2): 1454-1456
[11]
KuwaiT, KitadaiY, TankaS, et al.. Expression of hypoxia inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer, 2003, 105(2): 176-181
CrossRef Google scholar
[12]
RankinEB, GiacciaAJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ, 2008, 15(2): 678-685
[13]
OtrockZK, HatoumHA, AwadaAH, et al.. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives. Crit Rev Oncol Hematol, 2009, 70(2): 93-102
CrossRef Google scholar
[14]
KaelinWGJr.. How oxygen makes its presence felt. Genes Dev, 2002, 16(12): 1441-1445
CrossRef Google scholar
[15]
LiuLZ, JingY, JiangLL, et al.. Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1α pathway. Biochem Biophys Res Commun, 2011, 413(2): 299-305
CrossRef Google scholar
[16]
TapiaV, GablerF, MuñozM, et al.. Tyrosine kinase A receptor (trkA): A potential marker in epithelial ovarian cancer. Gynecol Oncol, 2011, 121(1): 13-23
CrossRef Google scholar
[17]
VumbacaF, PhoenixKN, Rodriguez-PintoD, et al.. Double-stranded RNA-binding protein regulates VEGF mRNA stability, translation and breast cancer angiogenesis. Mol Cell Biol, 2008, 28(2): 772-783
CrossRef Google scholar
[18]
NakamuraK, TanF, LiZ, et al.. NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1α. Mol Cell Neurosci, 2011, 46(2): 498-506
CrossRef Google scholar
[19]
RomonR, AdriaenssensE, LagadecC, et al.. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer, 2010, 9: 157
CrossRef Google scholar
[20]
Perez-PineraP, HernandezT, Garci’a-Sua’rezO, et al.. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas. Mol Cell Biol, 2007, 295(1–2): 19-26
[21]
CamposX, MuñozY, SelmanA, et al.. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer. Gynecol Oncol, 2007, 104(1): 168-175
CrossRef Google scholar
[22]
HongJ, QianT, LeQ, et al.. NGF promotes cell cycle progression by regulating D-type cyclins via PI3K/Akt and MAPK/Erk activation in human corneal epithelial cells. Mol Vis, 2012, 18: 758-764
[23]
ParkHJ, KimMN, KimJG, et al.. Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat. Biochim Biophys Acta, 2007, 1773(9): 1462-1472
CrossRef Google scholar
[24]
ReyS, SemenzaGL. Hypoxia-inducible factor-1 dependent mechanisms of vascularization and vascular remodeling. Cardiovasc Res, 2010, 86(2): 236-242
CrossRef Google scholar
[25]
DongX, WangYS, DouGR, et al.. Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions. PLOS One, 2011, 6(4): e18481
CrossRef Google scholar
[26]
HanzeJ, EulBG, SavaiR, et al.. RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation. Bioche Biophy Res Commun, 2003, 312(3): 571-577
CrossRef Google scholar
[27]
KimYS, JoDH, LeeH, et al.. Nerve growth factor-mediated vascular endothelial growth factor expression of astrocyte in retinal vascular development. Bioche Biophy Res Commun, 2013, 431(4): 740-745
CrossRef Google scholar
[28]
MartensLK, KirschnerKM, WarneckeC, et al.. Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene. J Biol Chem, 2007, 282(19): 14379-14388
CrossRef Google scholar

This project was supported by the Scientific Research Program of Health Department of Hubei Province, China (No. JX6B04).

Accesses

Citations

Detail

Sections
Recommended

/